Blood Cancer Talks
Blood Cancer Talks
This podcast focuses exclusively on the management of blood cancers and hematology. The twice-monthly episodes are hosted by Rajshekhar Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD.
Advertisement
Blood Cancer TalksBlood Cancer Talks | November 21, 2023
Alexander Perl, MD, joins the hosts to discuss the management of newly diagnosed and relapsed FLT3-positive AML.
Listen Now
Blood Cancer TalksBlood Cancer Talks | November 8, 2023
The episode also discusses Dr. Raza's book, "The First Cell," which recounts stories of her patients with terminal cancer.
Blood Cancer TalksBlood Cancer Talks | October 18, 2023
Kate Cwynarski, MBBS, PhD, of the University of College London, discusses the management of CNS lymphomas.
Blood Cancer TalksBlood Cancer Talks | October 18, 2023
This episode of "Blood Cancer Talks" discusses the biology and management of multiple myeloma and the role of venetoclax.
Blood Cancer TalksBlood Cancer Talks | October 2, 2023
The episode also highlights the S1211 study, which is the first randomized controlled trial with high-risk enrichment in MM.
Blood Cancer TalksBlood Cancer Talks | August 31, 2023
Dr. Horwitz and the hosts focus on the three most common types of PTCL and the latest research.
Advertisement
Blood Cancer TalksBlood Cancer Talks | August 21, 2023
Uma Borate, MBBS, joins the hosts to discuss CCUS and the latest data.
Cecilia BrownBlood Cancer Talks | July 31, 2023
Dr. Brodsky and the hosts discuss treatment options for PNH and key recent research on the subject.
Blood Cancer TalksBlood Cancer Talks | July 19, 2023
Dr. Bartlett and the hosts explore the history of first-line treatments for patients with Hodgkin lymphoma.
Blood Cancer TalksBlood Cancer Talks | June 30, 2023
Dr. Jain discusses how he addresses the acute toxicities that can arise after CAR T-cell therapy.
Blood Cancer TalksBlood Cancer Talks | June 24, 2023
The hosts discuss the latest data on CAR-T from the summer conference season.
Blood Cancer TalksMyeloproliferative Neoplasms | June 13, 2023
Dr. Sekeres also speaks about his time on the FDA ODAC and his latest book, titled "Drugs and the FDA."
Blood Cancer TalksBlood Cancer Talks | June 13, 2023
Dr. Chari and the hosts also discuss a phase I trial of fixed-duration cevostamab, as well as a phase I trial of ABBV-383.
Blood Cancer TalksMantle Cell Lymphoma | May 19, 2023
Dr. Dreyling discusses the management of newly diagnosed MCL and considerations in light of the TRIANGLE trial.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
The episode was inspired by an article titled “The Underrepresented Majority" by Andrés Gómez-De León, MD.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
Dr. Tefferi discusses risk stratification systems for primary myelofibrosis, transplant considerations, and more.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
Dr. Gertz and the hosts provide an overview of risk-stratification approaches and clinical trials in smoldering MM.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
Dr. DeZern discusses the latest research in the management of acquired aplastic anemia.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
Dr. Patel and the hosts discuss the phase III ASAP and Dauno-Double trials, menin inhibitors, and more.
Blood Cancer TalksBlood Cancer Talks | May 19, 2023
This episode provides listeners with DLBCL management strategies and an overview of the latest research in the field.
Advertisement
Advertisement
Editorial Board